$750 | Single User
$1500 | Site License
$2250 | Global License

Diazyme Laboratories Inc - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

Published by Global Data: 27 Dec 2018 | 228645 | In Stock

Introduction

Summary

Diazyme Laboratories Inc (Diazyme Laboratories) is a diagnostic reagents developer. The company offers test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. It offers products by markers, instrument specific packaging, point of care, DZ lite instrument, analyzer parameters, data sheets. Diazyme Laboratories offers anemia markers, cancer markers, cardiovascular markers, coagulation markers, diabetic markers, electrolyte markers, inflammatory markers, liver markers, renal and pancreatic marker, sepsis marker and vitamin marker. The company’s technology comprise enzyme cycling technology, latex enhanced immunoassay and enzyme-immunoassay. Diazyme Laboratories is headquartered in Poway, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Diazyme Laboratories Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Diazyme Laboratories Inc - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 4

    Diazyme Laboratories Inc Company Overview 5

    Diazyme Laboratories Inc Company Snapshot 5

    Diazyme Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview 5

    Diazyme Laboratories Inc – Pipeline Analysis Overview 8

    Diazyme Laboratories Inc - Key Facts 8

    Diazyme Laboratories Inc - Major Products and Services 9

    Diazyme Laboratories Inc Pipeline Products by Development Stage 10

    Diazyme Laboratories Inc Pipeline Products Overview 12

    B7-H4 Assay 12

    B7-H4 Assay Product Overview 12

    DcR3 (DD-C248) Assay 13

    DcR3 (DD-C248) Assay Product Overview 13

    MIC-1 (DD-X065) Assay 14

    MIC-1 (DD-X065) Assay Product Overview 14

    ProADM Point-of-Care 15

    ProADM Point-of-Care Product Overview 15

    ProADM Test 16

    ProADM Test Product Overview 16

    ProANP Test 17

    ProANP Test Product Overview 17

    ProET1 Test 18

    ProET1 Test Product Overview 18

    Spondin-2 (DD-P108) Assay 19

    Spondin-2 (DD-P108) Assay Product Overview 19

    TRAIL-R2 Assay 20

    TRAIL-R2 Assay Product Overview 20

    Diazyme Laboratories Inc - Key Competitors 21

    Diazyme Laboratories Inc - Key Employees 22

    Diazyme Laboratories Inc - Locations And Subsidiaries 23

    Head Office 23

    Other Locations & Subsidiaries 23

    Recent Developments 24

    Diazyme Laboratories Inc, Recent Developments 24

    Jul 16, 2018: Ortho Clinical Diagnostics Launches New MicroTip Partnership Assays for Diabetes, Cardiac and Renal Testing, In Collaboration with Diazyme Laboratories 24

    Jan 25, 2018: Stryker’s DAWN Trial results contribute to updated acute ischemic stroke guidelines from the American Heart Association and American Stroke Association 24

    Jan 22, 2018: FDA Grants Diazyme 510(k) Clearance to Market Its New EZ Vitamin D Assay for Clinical Chemistry Analyzers 25

    Jun 21, 2017: Beckman Coulter Diagnostics Expands Chemistry Menu to Include FDA-cleared Procalcitonin 25

    Nov 28, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Direct HbA1c (Enzymatic, On-Board Lysis) Assay for Clinical Chemistry Analyzers 25

    Nov 21, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Folate Assay for Clinical Chemistry Analyzers 26

    Nov 21, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Vitamin B12 Assay for Clinical Chemistry Analyzers 26

    Jul 22, 2016: Get Reliable Results with the Diazyme 25-OH Vitamin D Assay for Clinical Chemistry Analyzers 26

    May 23, 2016: Diadexus and Sonic Healthcare USA Sign National Agreement for PLAC Activity Test 27

    Nov 10, 2015: Diadexus Presents New PLAC Activity Data From the REGARDS Study at 2015 American Heart Association Scientific Sessions 27

    Appendix 29

    Methodology 29

    About GlobalData 32

    Contact Us 32

    Disclaimer 32

List Of Tables
in Diazyme Laboratories Inc - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

List of Tables

Diazyme Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Diazyme Laboratories Inc Pipeline Products by Equipment Type 6

Diazyme Laboratories Inc Pipeline Products by Indication 7

Diazyme Laboratories Inc, Key Facts 8

Diazyme Laboratories Inc, Major Products and Services 9

Diazyme Laboratories Inc Number of Pipeline Products by Development Stage 10

Diazyme Laboratories Inc Pipeline Products Summary by Development Stage 11

B7-H4 Assay - Product Status 12

B7-H4 Assay - Product Description 12

DcR3 (DD-C248) Assay - Product Status 13

DcR3 (DD-C248) Assay - Product Description 13

MIC-1 (DD-X065) Assay - Product Status 14

MIC-1 (DD-X065) Assay - Product Description 14

ProADM Point-of-Care - Product Status 15

ProADM Point-of-Care - Product Description 15

ProADM Test - Product Status 16

ProADM Test - Product Description 16

ProANP Test - Product Status 17

ProANP Test - Product Description 17

ProET1 Test - Product Status 18

ProET1 Test - Product Description 18

Spondin-2 (DD-P108) Assay - Product Status 19

Spondin-2 (DD-P108) Assay - Product Description 19

TRAIL-R2 Assay - Product Status 20

TRAIL-R2 Assay - Product Description 20

Diazyme Laboratories Inc, Key Employees 22

Diazyme Laboratories Inc, Subsidiaries 23

Glossary 31

List Of Figures, Charts and Diagrams
in Diazyme Laboratories Inc - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

List of Figures

Diazyme Laboratories Inc Pipeline Products by Equipment Type 6

Diazyme Laboratories Inc Pipeline Products by Development Stage 10

Additional Details

Publisher

Global Data

Publisher Information

Reference

228645 | GDME15831PD

Number of Pages

32

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Diazyme Laboratories Inc - Product Pipeline Analysis, 2017 Update
SummaryDiazyme Laboratories Inc (Diazyme Laboratories) is a developer of diagnostic reagents. The co...
27 Dec 2017 by Global Data USD $750 More Info

This report is published by Global Data

Download Free Report Summary PDF

Diazyme Laboratories Inc - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data